2m 2m 2m 2m 2m 2m 2m
TREACE MED CNCPT (TMCI)
NASDAQ
$4.50+$0.005 (+0.11%)
Price as of Jun 23, 2026 7:05 PM EDT- $260.1MMarket Cap
- -24.16%1-Year Change
- Medical DevicesIndustry
TREACE MED CNCPT (TMCI)
$4.50+$0.005 (+0.11%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 212.7M +1.59% | 209.4M +11.89% | 187.1M +31.92% | 141.8M +50.22% | |
Cost of Revenue | 42.9M +4.49% | 41.1M +16.80% | 35.2M +27.82% | 27.5M +54.40% | |
Gross Profit | 169.8M +0.88% | 168.3M +10.75% | 151.9M +32.91% | 114.3M +49.25% | |
Sales and Marketing Expense | 140.9M -4.58% | 147.6M +4.79% | 140.9M +37.36% | 102.6M +59.11% | |
Research and Development Expense | -20.3M -1.49% | -20.6M +33.35% | -15.4M +13.66% | -13.6M +33.12% | |
Depreciation and Amortization Expense | 10.6M +26.18% | 8.4M +57.31% | 5.4M +150.91% | 2.1M +211.39% | |
Total Operating Expenses | 223.9M -0.02% | 224.0M +10.12% | 203.4M +36.34% | 149.2M +60.21% | |
Operating Profit | -54.2M -2.75% | -55.7M +8.28% | -51.4M +47.59% | -34.8M +111.05% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -5.3M +1.22% | -5.3M +1.72% | -5.2M +17.49% | -4.4M +8.33% | |
Interest Income and Expense and Net | -5.3M +1.22% | -5.3M +1.72% | -5.2M +17.49% | -4.4M +8.33% | |
Total Nonoperating Income and Expense | -4.8M +8,714.55% | -55,000 -102.89% | 1.9M +123.85% | -8.0M +97.20% | |
Income before Taxes | -54.2M -2.75% | -55.7M +12.44% | -49.5M +15.68% | -42.8M +106.36% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 -100.00% | 300,000 N/A | |
Net Income | -59.0M +5.85% | -55.7M +12.55% | -49.5M +15.68% | -42.8M +108.33% | |
Net Income from Continuing Operations Applicable to Common | -59.0M +5.85% | -55.7M +12.55% | -49.5M +15.68% | -42.8M +106.36% | |
Basic EPS and Net Income | -0.93 +3.33% | -0.90 +11.11% | -0.81 +5.19% | -0.77 +79.07% | |
Diluted EPS and Net Income | -0.93 +3.33% | -0.90 +11.11% | -0.81 +5.19% | -0.77 +79.07% | |
Basic Weighted Average Shares | 63.3M +1.86% | 62.1M +2.07% | 60.9M +10.09% | 55.3M +14.17% | |
Diluted Weighted Average Shares | 63.3M +1.86% | 62.1M +2.07% | 60.9M +10.09% | 55.3M +14.17% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 10.7M -5.66% | 11.3M -12.57% | 13.0M -33.33% | 19.5M -81.60% | |
Short-Term Investments | 37.7M -41.46% | 64.3M -41.64% | 110.2M +78.40% | 61.8M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 48.4M -36.09% | 75.7M -38.57% | 123.2M +51.62% | 81.3M -23.23% | |
Total Current Assets | 132.1M -18.18% | 161.4M -18.63% | 198.4M +48.69% | 133.4M -3.31% | |
Accumulated Depreciation | 23.9M +55.96% | 15.3M +74.95% | 8.7M +105.21% | 4.3M +55.64% | |
Property and Plant and Equipment and Net | 29.8M +14.64% | 26.0M +16.39% | 22.3M +45.38% | 15.3M +438.36% | |
Total Long-Term Assets | 1.2M +200.00% | 407,000 +178.77% | 146,000 0.00% | 146,000 -94.88% | |
Total Assets | 190.6M -12.21% | 217.1M -13.82% | 251.9M +58.41% | 159.0M +12.93% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 155.7M +1.13% | 154.0M 0.00% | 154.0M 0.00% | 154.0M +8,512.98% | |
Total Current Liabilities | 30.6M -12.28% | 34.9M -22.45% | 45.0M +48.89% | 30.2M +66.09% | |
Total Long-Term Debt | 55.6M +4.27% | 53.3M +0.56% | 53.0M +0.56% | 52.7M +79.50% | |
Total Long-Term Liabilities | 3.0M +8,140.54% | 37,000 0.00% | 37,000 -99.95% | 68.3M +131.06% | |
Total Liabilities | 103.2M -0.91% | 104.2M -8.57% | 114.0M +15.71% | 98.5M +106.28% | |
Retained Earnings | -249.0M +31.06% | -190.0M +41.52% | -134.2M +58.46% | -84.7M +102.17% | |
Total Stockholders Equity | 87.3M -22.64% | 112.9M -18.16% | 137.9M +127.89% | 60.5M -34.97% | |
Total Shares Outstanding | 64.0M +2.64% | 62.4M +1.03% | 61.7M +11.00% | 55.6M +2.67% | |
Cash Flow | |||||
Cash from Operating Activities | -16.0M -57.03% | -37.2M +7.50% | -34.6M +12.81% | -30.6M +78.26% | |
Capital Expenditures | 13.5M +16.60% | 11.6M +1.18% | 11.5M -22.78% | 14.8M +448.54% | |
Cash from Investing Activities | 13.3M -62.54% | 35.4M +143.51% | -81.3M +6.25% | -76.5M +2,728.76% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.1M +1,198.13% | 160,000 -99.85% | 109.4M +425.73% | 20.8M -80.67% | |
Financials Ratio | |||||
Gross Margin | 79.81% -0.70% | 80.37% -1.02% | 81.20% +0.75% | 80.60% N/A | |
Operating Margin | -25.46% -4.28% | -26.60% -3.22% | -27.48% +11.88% | -24.57% N/A | |
Return on Assets | -28.95% +21.77% | -23.77% -1.38% | -24.10% -15.59% | -28.56% N/A | |
Return on Equity | -58.94% +32.60% | -44.45% -10.95% | -49.91% -10.47% | -55.75% N/A | |
Revenue Growth | 1.59% -86.60% | 11.89% -62.77% | 31.92% -36.43% | 50.22% N/A | |
Current Ratio | 4.31 -6.73% | 4.62 +4.92% | 4.40 -0.14% | 4.41 N/A | |
Cash Ratio | 0.35 +7.54% | 0.33 +12.73% | 0.29 -55.22% | 0.64 N/A | |
Debt-to-Equity Ratio | 2.42 +31.78% | 1.84 +22.36% | 1.50 -56.06% | 3.42 N/A | |
Debt-to-Assets Ratio | 1.11 +16.13% | 0.95 +16.20% | 0.82 -36.78% | 1.30 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow